P
Paul J. Perry
Researcher at Touro University California
Publications - 182
Citations - 9133
Paul J. Perry is an academic researcher from Touro University California. The author has contributed to research in topics: Olanzapine & Atypical antipsychotic. The author has an hindex of 51, co-authored 182 publications receiving 8664 citations. Previous affiliations of Paul J. Perry include University of Iowa Hospitals and Clinics & Roy J. and Lucille A. Carver College of Medicine.
Papers
More filters
Journal ArticleDOI
Lithium kinetics in single daily dosing.
TL;DR: The observation of no significant changes in either serum half‐lives or renal lithium clearance levels supports the conclusion that the average steady‐state lithium serum concentration (Cp88) is unchanged by conversion to single daily doses.
Journal ArticleDOI
Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients.
TL;DR: In spite of recent safety concerns for atypical antipsychotics, there is no increased risk of mortality in acutely ill pneumonia patients and a higher adjusted mortality rate for patients taking typical antipsychotic medications.
Journal Article
5-HT2A receptor promoter polymorphism, -1438G/A and negative symptom response to olanzapine in schizophrenia.
Vicki L. Ellingrod,Brian C. Lund,Del D. Miller,Frank Fleming,Paul J. Perry,Timothy L. Holman,Kristy Bever-Stille +6 more
TL;DR: It is concluded that the A/A genotype may be associated with olanzapine negative symptom response, seen as a 2-fold greater percent reduction in SANS, and may be clinically relevant.
Journal ArticleDOI
Sertraline-Phenelzine Drug Interaction: A Serotonin Syndrome Reaction
TL;DR: Selective serotonin reuptake inhibitor antidepressants should not be combined with monoamine oxidase inhibitor antidepressants because of the risk of serotonin syndrome.